Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.33% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.58% |
| 5 | Consumer Staples | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Highway Holdings
HIHO
$5.27M
| $479K | ﹤0.01% |
140,800
+1,900
| +1% | +$6.98K |
|
2802
TAL Education Group
TAL
$6.58B
| $479K | ﹤0.01% |
14,200
-775,400
| -98% | -$21.9M |
|
2803
Green Brick Partners
GRBK
$3.02B
| $478K | ﹤0.01% |
48,251
+21,614
| +81% | +$223K |
|
|
ZGNX
2804
DELISTED
Zogenix, Inc.
ZGNX
| $476K | ﹤0.01% |
+13,587
| New | +$184K |
|
2805
Genasys
GNSS
$77.4M
| $475K | ﹤0.01% |
223,200
-15,900
| -7% | -$27.1K |
|
|
SA
2806
Seabridge Gold
SA
$3.5B
| $475K | ﹤0.01% |
38,805
-12,200
| -24% | -$141K |
|
2807
Imunon
IMNN
$6.77M
| $473K | ﹤0.01% |
1,613
+479
| +42% | +$147K |
|
|
NBLX
2808
DELISTED
Noble Midstream Partners LP
NBLX
| $472K | ﹤0.01% |
9,100
-26,525
| -74% | -$1.23M |
|
2809
ReposiTrak
TRAK
$152M
| $469K | ﹤0.01% |
38,600
-17,627
| -31% | -$221K |
|
|
CMBT
2810
CMB.TECH NV
CMBT
$4.92B
| $467K | ﹤0.01% |
57,600
+11,200
| +24% | +$86.7K |
|
2811
Meritage Homes
MTH
$4.75B
| $466K | ﹤0.01% |
+21,000
| New | +$439K |
|
|
LMRK
2812
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $466K | ﹤0.01% |
27,500
+4,900
| +22% | +$82.2K |
|
|
GLBR
2813
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $465K | ﹤0.01% |
281,730
+10,500
| +4% | +$17.5K |
|
2814
Xenon Pharmaceuticals
XENE
$6.31B
| $461K | ﹤0.01% |
156,400
+26,100
| +20% | +$80.7K |
|
|
PFBX
2815
DELISTED
Peoples Financial Corp/MS
PFBX
| $460K | ﹤0.01% |
31,300
+1,100
| +4% | +$15.1K |
|
2816
ArcBest
ARCB
$3.14B
| $458K | ﹤0.01% |
13,700
-87,435
| -86% | -$2.3M |
|
|
STRM
2817
DELISTED
Streamline Health Solutions
STRM
| $456K | ﹤0.01% |
20,699
+752
| +4% | +$13.6K |
|
2818
MediWound
MDWD
$179M
| $455K | ﹤0.01% |
12,157
+714
| +6% | +$31.5K |
|
2819
Plumas Bancorp
PLBC
$439M
| $451K | ﹤0.01% |
21,600
+9,010
| +72% | +$184K |
|
|
CRT
2820
Cross Timbers Royalty Trust
CRT
$60.6M
| $448K | ﹤0.01% |
30,694
+12,782
| +71% | +$190K |
|
|
NRCIB
2821
DELISTED
National Research Corp Class B
NRCIB
| $446K | ﹤0.01% |
8,343
+2,343
| +39% | +$123K |
|
|
CYAN
2822
DELISTED
Cyanotech Corp
CYAN
| $442K | ﹤0.01% |
109,000
+4,000
| +4% | +$16.4K |
|
|
JMP
2823
DELISTED
JMP Group LLC
JMP
| $442K | ﹤0.01% |
78,733
+13,119
| +20% | +$71.5K |
|
|
WAAS
2824
DELISTED
AquaVenture Holdings Limited
WAAS
| $439K | ﹤0.01% |
32,500
-40,700
| -56% | -$620K |
|
|
ARCW
2825
DELISTED
ARC Group Worldwide, Inc
ARCW
| $439K | ﹤0.01% |
186,600
+300
| +0.2% | +$768 |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.